|
US654472A
(en)
*
|
1900-02-03 |
1900-07-24 |
George A Mayer |
Hub-attaching device.
|
|
DE1643310A1
(de)
|
1966-12-29 |
1971-06-03 |
Dow Chemical Co |
4-Alkyl-2,5-dimethoxy-alpha-methyl-phenaethylamin und seine pharmakologisch vertraeglichen Salze
|
|
US4099012A
(en)
|
1975-08-28 |
1978-07-04 |
Ciba-Geigy Corporation |
2-pyrazolyl-benzophenones
|
|
DE2926517A1
(de)
|
1979-06-30 |
1981-01-15 |
Beiersdorf Ag |
Substituierte 3-aryl-pyrazole und 5-aryl-isoxazole und verfahren zu ihrer herstellung
|
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
|
IL61721A
(en)
|
1980-12-16 |
1984-03-30 |
Blank Izhak |
Nitroglycerin preparations
|
|
US4555399A
(en)
|
1983-11-18 |
1985-11-26 |
Key Pharmaceuticals, Inc. |
Aspirin tablet
|
|
US4985352A
(en)
|
1988-02-29 |
1991-01-15 |
The Trustees Of Columbia University In The City Of New York |
DNA encoding serotonin 1C (5HT1c) receptor, isolated 5HT1c receptor, mammalian cells expressing same and uses thereof
|
|
IT1227626B
(it)
|
1988-11-28 |
1991-04-23 |
Vectorpharma Int |
Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
|
|
JPH03135978A
(ja)
|
1989-08-08 |
1991-06-10 |
Merck Sharp & Dohme Ltd |
置換ピリジン、その製法、処方並びに痴呆症における使用法
|
|
US5661024A
(en)
|
1989-10-31 |
1997-08-26 |
Synaptic Pharmaceutical Corporation |
DNA encoding a human serotonic (5-HT2) receptor and uses thereof
|
|
US5128351A
(en)
|
1990-05-04 |
1992-07-07 |
American Cyanamid Company |
Bis-aryl amide and urea antagonists of platelet activating factor
|
|
US5077409A
(en)
|
1990-05-04 |
1991-12-31 |
American Cyanamid Company |
Method of preparing bis-aryl amide and urea antagonists of platelet activating factor
|
|
JPH04334357A
(ja)
|
1991-05-02 |
1992-11-20 |
Fujirebio Inc |
酵素阻害作用を有するアシル誘導体
|
|
FR2682379B1
(fr)
|
1991-10-09 |
1994-02-11 |
Rhone Poulenc Agrochimie |
Nouveaux phenylpyrazoles fongicides.
|
|
FR2690440B1
(fr)
|
1992-04-27 |
1995-05-19 |
Rhone Poulenc Agrochimie |
Arylpyrazoles fongicides.
|
|
US5905080A
(en)
|
1993-08-20 |
1999-05-18 |
Smithkline Beecham, P.L.C. |
Amide and urea derivatives as 5HT1D receptor antagonists
|
|
FR2722369B1
(fr)
|
1994-07-13 |
1998-07-10 |
Rhone Poulenc Agrochimie |
Compositions fongicides a base de derives 3-phenyl-pyrazoles pour le traitement du materiel vegetal de multiplication, nouveaux derives 3-phenyl-pyrazoles et leurs applications fongicides
|
|
AU3577995A
(en)
|
1994-10-04 |
1996-04-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Urea derivatives and their use as acat-inhibitors
|
|
CA2135253A1
(en)
|
1994-11-07 |
1996-05-08 |
Michael Dennis |
Compound screening based on a window of chemical-messenger-independent activity
|
|
FI973205L
(fi)
|
1995-02-02 |
1997-10-01 |
Smithkline Beecham Plc |
Indolijohdannaisia 5-HT-reseptoriantagonisteina
|
|
US6540981B2
(en)
|
1997-12-04 |
2003-04-01 |
Amersham Health As |
Light imaging contrast agents
|
|
EP0809492A4
(en)
|
1995-02-17 |
2007-01-24 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
|
US5856326A
(en)
|
1995-03-29 |
1999-01-05 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO1996032931A2
(en)
|
1995-04-20 |
1996-10-24 |
Vectorpharma International S.P.A. |
Composite with sodium starch glycolate as a support material and products thereof
|
|
US5861431A
(en)
|
1995-06-07 |
1999-01-19 |
Iotek, Inc. |
Incontinence treatment
|
|
WO1997003967A1
(en)
|
1995-07-22 |
1997-02-06 |
Rhone-Poulenc Rorer Limited |
Substituted aromatic compounds and their pharmaceutical use
|
|
US6054472A
(en)
|
1996-04-23 |
2000-04-25 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of IMPDH enzyme
|
|
US6005008A
(en)
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
GB9607219D0
(en)
|
1996-04-04 |
1996-06-12 |
Smithkline Beecham Plc |
Novel compounds
|
|
WO1997045111A1
(en)
|
1996-05-24 |
1997-12-04 |
Neurosearch A/S |
Phenyl derivatives useful as blockers of chloride channels
|
|
JP4073489B2
(ja)
|
1996-05-24 |
2008-04-09 |
ニューロサーチ・アクティーゼルスカブ |
酸性基を有するフエニル誘導体、その製造方法及びそれをクロライドチャンネル遮断剤として使用する方法
|
|
PL330849A1
(en)
|
1996-06-27 |
1999-06-07 |
Smithkline Beecham Corp |
Antagonists of il-8 receptors
|
|
EP0932401A1
(en)
|
1996-07-01 |
1999-08-04 |
Sepracor, Inc. |
Methods and compositions for treating urinary incontinence using enantiomerically enriched (r,r)-glycopyrrolate
|
|
EP0920313A1
(en)
|
1996-07-01 |
1999-06-09 |
Sepracor, Inc. |
Methods and compositions for treating urinary incontinence using enantiomerically enriched (s,s)-glycopyrrolate
|
|
AU721653B2
(en)
|
1996-10-25 |
2000-07-13 |
Supernus Pharmaceuticals, Inc. |
Soluble form osmotic dose delivery system
|
|
JP2001508767A
(ja)
|
1996-12-02 |
2001-07-03 |
藤沢薬品工業株式会社 |
５―ｈｔ拮抗作用を有するインドール―ウレア誘導体
|
|
US6420541B1
(en)
|
1998-04-14 |
2002-07-16 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
|
US6541209B1
(en)
|
1997-04-14 |
2003-04-01 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
|
US6696475B2
(en)
|
1997-04-22 |
2004-02-24 |
Neurosearch A/S |
Substituted phenyl derivatives, their preparation and use
|
|
CN1118462C
(zh)
|
1997-04-22 |
2003-08-20 |
神经研究公司 |
取代的苯基衍生物、其制备方法以及用途
|
|
US6028083A
(en)
*
|
1997-07-25 |
2000-02-22 |
Hoechst Marion Roussel, Inc. |
Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
|
|
AU8673198A
(en)
|
1997-07-29 |
1999-02-22 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
AU750125B2
(en)
|
1997-08-27 |
2002-07-11 |
Hexal Ag |
New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
|
|
NZ503407A
(en)
|
1997-10-31 |
2002-08-28 |
Aventis Pharma Ltd |
Anilide derivatives useful for treating inflammatory diseases
|
|
JPH11183942A
(ja)
|
1997-12-19 |
1999-07-09 |
Nippon Mitsubishi Oil Corp |
エレクトロクロミック素子
|
|
WO1999032463A1
(en)
|
1997-12-22 |
1999-07-01 |
Bayer Corporation |
INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
|
|
EP1049664B1
(en)
|
1997-12-22 |
2005-03-16 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
|
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
AU764766B2
(en)
|
1998-04-14 |
2003-08-28 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
|
US6140509A
(en)
|
1998-06-26 |
2000-10-31 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
|
GB9816263D0
(en)
|
1998-07-24 |
1998-09-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US6358698B1
(en)
|
1998-10-07 |
2002-03-19 |
Acadia Pharmacueticals Inc. |
Methods of identifying inverse agonists of the serotonin 2A receptor
|
|
SK5222001A3
(en)
|
1998-10-22 |
2002-05-09 |
Neurosearch As |
Substituted phenyl derivatives, their preparation and use
|
|
US6150393A
(en)
*
|
1998-12-18 |
2000-11-21 |
Arena Pharmaceuticals, Inc. |
Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors
|
|
US6180138B1
(en)
|
1999-01-29 |
2001-01-30 |
Abbott Laboratories |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
|
|
ES2345921T3
(es)
|
1999-03-26 |
2010-10-06 |
Euro-Celtique S.A. |
Pirazoles, imidazoles, oxazoles, tiazoles y pirroles sustituidos con arilo y su uso.
|
|
GB9909409D0
(en)
|
1999-04-24 |
1999-06-23 |
Zeneca Ltd |
Chemical compounds
|
|
US6469006B1
(en)
*
|
1999-06-15 |
2002-10-22 |
Bristol-Myers Squibb Company |
Antiviral indoleoxoacetyl piperazine derivatives
|
|
IT1312115B1
(it)
|
1999-06-24 |
2002-04-04 |
Nicox Sa |
Composti amorfi e relative composizioni farmaceutiche
|
|
CA2382755A1
(en)
|
1999-07-28 |
2001-02-01 |
Aventis Pharmaceuticals Products Inc. |
Substituted oxoazaheterocyclyl compounds
|
|
US6541477B2
(en)
|
1999-08-27 |
2003-04-01 |
Scios, Inc. |
Inhibitors of p38-a kinase
|
|
WO2001021160A2
(en)
|
1999-09-23 |
2001-03-29 |
Axxima Pharmaceuticals Aktiengesellschaft |
Carboxymide and aniline derivatives as selective inhibitors of pathogens
|
|
US6531291B1
(en)
|
1999-11-10 |
2003-03-11 |
The Trustees Of Columbia University In The City Of New York |
Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof
|
|
EP1108720A1
(en)
|
1999-12-08 |
2001-06-20 |
Basf Aktiengesellschaft |
Herbicidal 2-Pyrazolyl-6-Aryloxy-Pyri(mi)dines
|
|
EP1248770A1
(en)
|
1999-12-16 |
2002-10-16 |
Biostream Therapeutics |
1,3,4-substituted piperidine analogs and uses thereof in treating addictions
|
|
MXPA02006137A
(es)
|
1999-12-20 |
2002-12-05 |
Neuromed Tech Inc |
Bloqueadores del canal de calcio parcialmente saturados.
|
|
AU2001241927A1
(en)
|
2000-02-28 |
2001-09-12 |
Scios Inc. |
Inhibitors of p38-alpha kinase
|
|
FR2810979B1
(fr)
|
2000-06-29 |
2002-08-23 |
Adir |
Nouveaux derives de diphenyluree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
GB0021885D0
(en)
|
2000-09-06 |
2000-10-18 |
Fujisawa Pharmaceutical Co |
New use
|
|
WO2002039987A2
(en)
|
2000-11-14 |
2002-05-23 |
Neurosearch A/S |
Use of malaria parasite anion channel blockers for treating malaria
|
|
AR035521A1
(es)
|
2000-12-22 |
2004-06-02 |
Lundbeck & Co As H |
Derivados de 3-indolina y composicion farmaceutica que los comprende
|
|
JP2004520347A
(ja)
|
2001-01-15 |
2004-07-08 |
グラクソ グループ リミテッド |
Ｌｄｌ−受容体発現のインデューサーとしてのアリールピペリジンおよびピペラジン誘導体
|
|
WO2002076464A1
(en)
|
2001-03-22 |
2002-10-03 |
Arena Pharmaceuticals, Inc. |
Anti-psychosis combination
|
|
DE60223382T2
(de)
|
2001-06-29 |
2008-09-11 |
Eurand Pharmaceuticals Ltd., Bray |
Verfahren für die thermodynamische aktivierung von wasserlöslichen arzneimitteln, die in vernetzten polymeren geladen sind
|
|
JP4733877B2
(ja)
|
2001-08-15 |
2011-07-27 |
富士通セミコンダクター株式会社 |
半導体装置
|
|
EP1427415B1
(en)
|
2001-09-21 |
2009-08-12 |
Brystol-Myers Squibb Company |
Lactam-containing compounds and derivatives thereof as factor xa inhibitors
|
|
WO2003062206A2
(en)
|
2002-01-23 |
2003-07-31 |
Arena Pharmaceuticals, Inc. |
Small molecule modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
|
US6743864B2
(en)
|
2002-03-12 |
2004-06-01 |
Basell Poliolefine Italia S.P.A. |
Polyolefin compositions having high tenacity
|
|
AU2003298514A1
(en)
|
2002-05-17 |
2004-05-04 |
Eisai Co., Ltd. |
Methods and compositions using cholinesterase inhibitors
|
|
AU2003275093A1
(en)
|
2002-09-24 |
2004-04-19 |
Arena Pharmaceuticals, Inc. |
Process of making phenylpyrazoles useful as selective 5ht2a modulators and intermediates thereof
|
|
US7635709B2
(en)
|
2002-09-26 |
2009-12-22 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Compositions and methods for bowel care in individuals with chronic intestinal pseudo-obstruction
|
|
WO2004045118A2
(en)
|
2002-11-08 |
2004-05-27 |
Interdigital Technology Corporation |
Composite channel quality estimation techniques for wireless receivers
|
|
JPWO2004046110A1
(ja)
|
2002-11-15 |
2006-03-16 |
アステラス製薬株式会社 |
メラニン凝集ホルモン受容体拮抗剤
|
|
US7247628B2
(en)
*
|
2002-12-12 |
2007-07-24 |
Pfizer, Inc. |
Cannabinoid receptor ligands and uses thereof
|
|
WO2004058722A1
(en)
|
2002-12-24 |
2004-07-15 |
Arena Pharmaceuticals, Inc. |
Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
|
|
WO2004071426A2
(en)
|
2003-02-11 |
2004-08-26 |
Kemia Inc. |
Compounds for the treatment of viral infection
|
|
WO2004085433A2
(en)
|
2003-03-28 |
2004-10-07 |
Pharmacia & Upjohn Company Llc |
Positive allosteric modulators of the nicotinic acetylcholine receptor
|
|
GB0309781D0
(en)
|
2003-04-29 |
2003-06-04 |
Glaxo Group Ltd |
Compounds
|
|
FR2855825B1
(fr)
*
|
2003-06-04 |
2008-08-22 |
Aventis Pharma Sa |
Produits aryl-heteroaromatiques, compositions les contenant et utilisation
|
|
EP1558582B1
(en)
|
2003-07-22 |
2005-12-21 |
Arena Pharmaceuticals, Inc. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
|
EP1695966A1
(en)
|
2003-07-22 |
2006-08-30 |
Arena Pharmaceuticals, Inc. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
|
US7514438B2
(en)
|
2003-08-13 |
2009-04-07 |
Amgen, Inc. |
Melanin concentrating hormone receptor antagonist
|
|
US7091236B1
(en)
|
2003-08-20 |
2006-08-15 |
Sciele Pharma, Inc. |
Method for increasing the bioavailability of glycopyrrolate
|
|
US20050054691A1
(en)
|
2003-08-29 |
2005-03-10 |
St. Jude Children's Research Hospital |
Carboxylesterase inhibitors
|
|
CA2537364A1
(en)
|
2003-09-03 |
2005-03-10 |
Galapagos Nv |
Imidazo[1,5-a]pyridine or imidazo[1,5-a]piperidine derivatives and their use for the preparation of medicament against 5-ht2a receptor-related disorders
|
|
DE10354604B4
(de)
*
|
2003-11-21 |
2016-10-13 |
Gesellschaft für Aufladetechnik und Spindelbau mbH |
Stufenlos schaltbares, magnetodynamisches Getriebe
|
|
WO2005077345A1
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Compounds for the treatment of gastro-esophageal reflux disease
|
|
CN1926114B
(zh)
|
2004-03-23 |
2011-08-24 |
艾尼纳制药公司 |
用于制备经取代n-芳基-n′-′3-(1h-吡唑-5-基)苯基脲及其中间体的方法
|
|
US20060014705A1
(en)
|
2004-06-30 |
2006-01-19 |
Howitz Konrad T |
Compositions and methods for selectively activating human sirtuins
|
|
US20060172992A1
(en)
|
2004-08-13 |
2006-08-03 |
Eisai Co., Ltd. |
Therapeutic agent for overactive bladder resulting from cerebral infarction
|
|
JP2008509982A
(ja)
|
2004-08-16 |
2008-04-03 |
プロシディオン・リミテッド |
アリール尿素誘導体
|
|
US20060063754A1
(en)
|
2004-09-21 |
2006-03-23 |
Edgar Dale M |
Methods of treating a sleep disorder
|
|
CA2584485C
(en)
|
2004-10-20 |
2013-12-31 |
Resverlogix Corp. |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
|
US20090239841A1
(en)
|
2004-10-27 |
2009-09-24 |
Hutchison Alan J |
Diaryl Ureas as CB1 Antagonists
|
|
WO2006049734A2
(en)
|
2004-10-29 |
2006-05-11 |
Hypnion, Inc. |
Quetiapine analogs and methods of use thereof
|
|
CA2585471A1
(en)
|
2004-11-01 |
2006-05-11 |
Seo Hong Yoo |
Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
|
|
PE20061130A1
(es)
|
2004-11-19 |
2007-01-05 |
Arena Pharm Inc |
Derivados de 3-fenil-pirazol como moduladores del receptor de serotonina 5-ht2a
|
|
GB0426313D0
(en)
|
2004-12-01 |
2005-01-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2006060654A2
(en)
|
2004-12-01 |
2006-06-08 |
Divergence, Inc. |
Pesticidal compositions and methods
|
|
WO2006060762A2
(en)
|
2004-12-03 |
2006-06-08 |
Arena Pharmaceuticals, Inc. |
Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
DE102004061593A1
(de)
|
2004-12-21 |
2006-06-22 |
Abbott Gmbh & Co. Kg |
Substituierte N-heterocyclische Verbindungen und ihre therapeutische Verwendung
|
|
WO2006070394A1
(en)
|
2004-12-28 |
2006-07-06 |
Council Of Scientific And Industrial Research |
Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors
|
|
ES2465469T3
(es)
|
2005-01-14 |
2014-06-05 |
Gilead Connecticut, Inc. |
Diaril ureas 1,3-sustituidas como moduladores de la actividad quinasa
|
|
CN101160127A
(zh)
|
2005-01-19 |
2008-04-09 |
艾尼纳制药公司 |
用于预防或治疗进行性多灶性白质脑病而作为5-ht2a血清素受体调节剂的二芳基和芳基杂芳基脲衍生物
|
|
CA2595483A1
(en)
|
2005-01-21 |
2006-07-27 |
Teva Pharmaceutical Industries Ltd. |
Stable pharmaceutical formulations of zonisamide and methods for their manufacture
|
|
AR052886A1
(es)
|
2005-01-26 |
2007-04-11 |
Arena Pharm Inc |
Procedimientos para preparar fenilpirazol ureas sustituidas y para la obtencion de sus intermediarios de sintesis
|
|
MX2007009092A
(es)
|
2005-01-27 |
2007-09-12 |
Janssen Pharmaceutica Nv |
Derivados de tetrahidrofurano tetraciclicos heterociclicos como inhibidores de 5ht2 en el tratamiento de trastornos del sistema nervioso central.
|
|
GT200600042A
(es)
|
2005-02-10 |
2006-09-27 |
Aventis Pharma Inc |
Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
|
|
WO2006089871A2
(en)
|
2005-02-23 |
2006-08-31 |
Neurosearch A/S |
Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias
|
|
GB0504828D0
(en)
|
2005-03-09 |
2005-04-13 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB0505437D0
(en)
|
2005-03-17 |
2005-04-20 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB0505725D0
(en)
|
2005-03-19 |
2005-04-27 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
TWI320783B
(en)
|
2005-04-14 |
2010-02-21 |
Otsuka Pharma Co Ltd |
Heterocyclic compound
|
|
ES2340066T3
(es)
|
2005-04-26 |
2010-05-28 |
Hypnion, Inc. |
Compuestos de benzisoxazol piperidina y procedimiento de uso de los mismos.
|
|
EP1734039A1
(en)
|
2005-06-13 |
2006-12-20 |
Esbatech AG |
Aryl urea compounds as BETA-secretase inhibitors
|
|
WO2007002563A1
(en)
|
2005-06-27 |
2007-01-04 |
Exelixis, Inc. |
Imidazole based lxr modulators
|
|
US7754724B2
(en)
|
2005-06-30 |
2010-07-13 |
Dow Agrosciences Llc |
N-substituted piperazines
|
|
US8093401B2
(en)
|
2005-08-04 |
2012-01-10 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
US7544685B2
(en)
|
2005-08-17 |
2009-06-09 |
H. Lundbeck A/S |
2,3-dihydroindole compounds
|
|
AR055203A1
(es)
|
2005-08-31 |
2007-08-08 |
Otsuka Pharma Co Ltd |
Derivados de benzotiofeno con propiedades antipsicoticas
|
|
EP1928430A1
(en)
|
2005-09-29 |
2008-06-11 |
Arena Pharmaceuticals, Inc. |
Pharmaceutical compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto
|
|
EP2004627A2
(en)
|
2006-04-10 |
2008-12-24 |
Arena Pharmaceuticals, Inc. |
3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
GB0608655D0
(en)
|
2006-05-03 |
2006-06-14 |
Merck Sharp & Dohme |
Therapeutic Treatment
|
|
EP2051978A2
(en)
|
2006-05-18 |
2009-04-29 |
Arena Pharmaceuticals, Inc. |
Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
EA016675B1
(ru)
|
2006-05-18 |
2012-06-29 |
Арена Фармасьютикалз, Инк. |
Способы получения фенилпиразолов и кристаллическая форма производного фенилпиразола
|
|
WO2007136680A2
(en)
|
2006-05-18 |
2007-11-29 |
Arena Pharmaceuticals, Inc. |
3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
USRE45336E1
(en)
|
2006-05-18 |
2015-01-13 |
Arena Pharmaceuticals, Inc. |
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
|
|
JP2010502618A
(ja)
|
2006-08-31 |
2010-01-28 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
セロトニン５−ｈｔ２ａ受容体のモジュレータとしてのベンゾフラン誘導体
|
|
TWI415845B
(zh)
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
|
|
TW200823204A
(en)
|
2006-10-17 |
2008-06-01 |
Arena Pharm Inc |
Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine H3-receptor useful for the treatment of disorders related thereto
|
|
WO2008054748A2
(en)
|
2006-10-31 |
2008-05-08 |
Arena Pharmaceuticals, Inc. |
Indazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
US8097633B2
(en)
|
2006-11-15 |
2012-01-17 |
Rich Steven A |
Uses for quaternary ammonium anticholinergic muscarinic receptor antagonists in patients being treated for cognitive impairment or acute delirium
|
|
US9034890B2
(en)
|
2006-11-15 |
2015-05-19 |
Steven A. Rich |
Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases
|
|
US8969402B2
(en)
|
2006-11-15 |
2015-03-03 |
Steven A. Rich |
Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases
|
|
WO2008073825A1
(en)
*
|
2006-12-08 |
2008-06-19 |
Exelixis, Inc. |
Lxr and fxr modulators
|
|
US9567327B2
(en)
|
2007-08-15 |
2017-02-14 |
Arena Pharmaceuticals, Inc. |
Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
|
|
EP2254564A1
(en)
|
2007-12-12 |
2010-12-01 |
Glaxo Group Limited |
Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
|
|
US20110021538A1
(en)
|
2008-04-02 |
2011-01-27 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
|
TR201805216T4
(en)
|
2008-10-28 |
2018-06-21 |
Arena Pharm Inc |
COMPOSITIONS OF A USEFUL 5-HT2A SEROTONINE RECEPTOR MODULATOR FOR THE TREATMENT OF RELATED DISORDERS
|
|
WO2010062321A1
(en)
|
2008-10-28 |
2010-06-03 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
|
|
GB201111712D0
(en)
|
2011-07-08 |
2011-08-24 |
Gosforth Ct Holdings Pty Ltd |
Pharmaceutical compositions
|
|
HK1212609A1
(zh)
|
2012-10-25 |
2016-06-17 |
大塚制药株式会社 |
含有依匹唑派或其盐的用於与神经变性疾病相关的行为和精神症状或与精神疾病相关的冲动症状的预防和/或治疗剂
|
|
WO2014085362A1
(en)
|
2012-11-27 |
2014-06-05 |
Acadia Pharmaceuticals Inc. |
Methods for the treatment of parkinson's disease psychosis using pimavanserin
|
|
KR101472682B1
(ko)
|
2013-07-23 |
2014-12-15 |
고려대학교 산학협력단 |
메타물질 제조 방법, 이에 의해 제조된 메타물질 구조 필름 및 이를 이용한 광학 이미징 시스템
|
|
WO2017011767A2
(en)
|
2015-07-15 |
2017-01-19 |
Axovant Sciences Ltd. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease
|